Electrospun Materials for Biomedical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (20 May 2022) | Viewed by 44662
Special Issue Editors
Interests: cyclodextrin; polymer; electrospinning; chromism; hybrid materials
Special Issues, Collections and Topics in MDPI journals
Interests: biopolymers; nanocomposites; medical and pharmaceutical devices; biological control
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Electrospun fibers have attracted much attention because of their potential applications for a broad spectrum of applications, including those related to environmental protection, heterogeneous catalysis, smart materials, surface coating, encapsulation of bioactive species, drug delivery, tissue engineering, and regenerative medicine. These fibers have been electrospun using natural, synthetic or hybrid materials to deliver drugs, grown factors, proteins, DNA, RNA, and so on. Electrospinning has been considered a versatile method capable of producing polymeric fibers, ranging from micrometers to ultrafine ones, being assembled into ordered arrays or hierarchical structures (e.g., uniaxial, coaxial, and Janus, among others). Electrospun fibers used for biomedical applications have taken advantage of their high surface area to volume ratio, tunable porosity, mechanical properties, favorable environment for drug insertion, biocompatibility, and capability of further surface and/or interior functionalization. In this sense, the development of long-acting drug formulations using electrospinning approach has been investigated to overcome challenges with drug resistance and tissue engineering.
Prof. Dr. Frederico B. De Sousa
Prof. Dr. Hernane S. Barud
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- electrospinning
- polymers
- fibers
- materials
- drug delivery